Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.7432
-0.0214 (-2.80%)
At close: Dec 11, 2025, 4:00 PM EST
0.7600
+0.0168 (2.26%)
Pre-market: Dec 12, 2025, 6:30 AM EST
Harvard Bioscience Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$2.50
Upside
+236.38%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $3 → $2 | Buy | Maintains | $3 → $2 | +169.11% | Sep 10, 2025 |
| Benchmark | Benchmark | Buy Maintains $4.5 → $3 | Buy | Maintains | $4.5 → $3 | +303.66% | May 13, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
| Benchmark | Benchmark | Buy Maintains $5.5 → $4.5 | Buy | Maintains | $5.5 → $4.5 | +505.49% | Mar 24, 2025 |
| Benchmark | Benchmark | Buy Reiterates $7 | Buy | Reiterates | $7 | +841.87% | Jun 22, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | +841.87% | Apr 26, 2023 |
| Keybanc | Keybanc | Buy Maintains $5 → $7 | Buy | Maintains | $5 → $7 | +841.87% | Apr 26, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +438.21% | Mar 10, 2023 |
| Keybanc | Keybanc | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +572.77% | Nov 9, 2022 |
| Keybanc | Keybanc | Buy Maintains $10 → $7 | Buy | Maintains | $10 → $7 | +841.87% | Aug 5, 2022 |
| Keybanc | Keybanc | Buy Initiates $6 | Buy | Initiates | $6 | +707.32% | Nov 10, 2020 |
| Benchmark | Benchmark | Buy Maintains $3.5 → $4 | Buy | Maintains | $3.5 → $4 | +438.21% | Feb 27, 2020 |
| Benchmark | Benchmark | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +976.43% | Jul 28, 2015 |